The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Albemarle's revenues will decrease -4.8% and EPS will compress -21.0%.
The average estimate for revenue is $651.8 million. On the bottom line, the average EPS estimate is $0.98.
Last quarter, Albemarle notched revenue of $641.6 million. GAAP reported sales were 9.8% lower than the prior-year quarter's $711.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.93. GAAP EPS of $0.94 for Q1 were 26% lower than the prior-year quarter's $1.27 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 31.1%, 420 basis points worse than the prior-year quarter. Operating margin was 17.9%, 320 basis points worse than the prior-year quarter. Net margin was 13.1%, 300 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $2.73 billion. The average EPS estimate is $4.67.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 219 members out of 234 rating the stock outperform, and 15 members rating it underperform. Among 66 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 65 give Albemarle a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Albemarle is hold, with an average price target of $71.83.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Albemarle to My Watchlist.